Just APPROVED in the EU. Today ..........Watch for $14 Per Share.
Major buy opportunity. Remember, the CEO bought $500K of stock at $11.34 so this is currently better price than he got. Expect a slow rise back to $15 by end of year. Next week we should see them announce commercial availability in US for linaclotide and first sales of the drug.